Details of the Drug Reposition

General Information of This Drug (ID: DMNSAND)

Drug Name
Evolocumab   DMNSAND
Synonyms Repatha
Drug Type
Monoclonal antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hypercholesterolaemia DIS9U23P 5C80.0 Approved [1]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Syndromic dyslipidemia DISPGGVL N.A. Discontinued in Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Impact of alirocumab/evolocumab on lipoprotein (a) concentrations in patients with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized controlled trials. Endokrynol Pol. 2023;74(3):234-242.
2 Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies